PRAX
NASDAQ · Biotechnology
Praxis Precision Medicines I
$277.62
+15.03 (+5.72%)
Performance
1D
+0.00%
1W
+1.32%
1M
+5.34%
3M
-24.35%
6M
-16.33%
1Y
+65.03%
YTD
-3.07%
Open$267.28
Previous Close$262.59
Day High$278.98
Day Low$260.77
52W High$392.70
52W Low$154.45
Volume—
Avg Volume351.9K
Market Cap7.75B
P/E Ratio—
EPS$-13.37
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$291.73
Below
SMA 200
$313.95
Below
RSI (14)
57.3
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
25 analysts
Price Target
-93.0% upside
Current
$277.62
$277.62
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.03M | 1.51B | 1.36B |
| Net Income | -278,552,680 | -397,237,584 | -445,831,143 |
| Profit Margin | -2,137.5% | -26.4% | -32.9% |
| EBITDA | -304,436,703 | -626,558,933 | -546,408,810 |
| Free Cash Flow | — | -309,826,002 | -348,261,984 |
| Rev Growth | — | +19.5% | +13.8% |
| Debt/Equity | — | 0.24 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |